Accelerated development of appropriate patient therapies: a sustainable, multi-stakeholder approach from research to treatment-outcomes
The Innovative Health Initiative builds on the successes of the Innovative Medicines Initiative (IMI), which launched over 180 projects. Many IMI projects are still ongoing and are monitored by the IHI Programme Office. This section features the factsheets of all IMI projects. Once IHI projects are up and running, we will also promote them here.
Displaying 34 projects/programmes
Combatting bacterial resistance in Europe - molecules against Gram negative infections
Framework for clinical trial participants data reutilization for a fully transparent and ethical ecosystem
Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases
Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes.
Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA
New clinical endpoints in primary Sjögren’s syndrome: an interventional trial based on stratifying patients
Patients active in research and dialogues for an improved generation of medicines: advancing meaningful patient engagement in the life cycle of medicines for better health outcomes
Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development
Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD
Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification
Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials